INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the FirmBusiness Wire • 06/29/23
Regeneron drops as US FDA declines to approve higher-dose version of its eye disease treatmentProactive Investors • 06/28/23
Regeneron Stock Crumbles After FDA Rejects Its Next Blockbuster ContenderInvestors Business Daily • 06/27/23
Two-year Results for Aflibercept 8 mg from Pivotal PHOTON Trial Demonstrate Durable Vision Gains at Extended Dosing Intervals in Diabetic Macular EdemaGlobeNewsWire • 06/27/23
FDA Issues Complete Response Letter (CRL) for Aflibercept 8 mg Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-party FillerGlobeNewsWire • 06/27/23
Regeneron Pharmaceuticals Inc. (REGN) Presents at Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/14/23
Regeneron Pharmaceuticals, Inc. (REGN) Jefferies Global Healthcare Conference (Transcript)Seeking Alpha • 06/07/23
Regeneron Pharmaceuticals, Inc. (REGN) TD Cowen 4th Annual Oncology Innovation Summit (Transcript)Seeking Alpha • 05/30/23
Updated Linvoseltamab (BCMAxCD3) Data from Pivotal Trial Demonstrates Early, Deep and Durable Responses in Patients with Heavily Pre-treated Multiple MyelomaGlobeNewsWire • 05/25/23
Fianlimab (LAG-3 inhibitor) Combined with Libtayo® (cemiplimab) Shows Clinically Meaningful and Durable Tumor Responses Across Key Advanced Melanoma Patient PopulationsGlobeNewsWire • 05/25/23
Dupixent® (dupilumab) Late-breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of MedicineGlobeNewsWire • 05/21/23
Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of MedicineGlobeNewsWire • 05/21/23
High School Scientists and Engineers Win Nearly $9 Million at the Regeneron International Science and Engineering Fair 2023PRNewsWire • 05/19/23
High School Scientists and Engineers Win Nearly $9 Million at the Regeneron International Science and Engineering Fair 2023GlobeNewsWire • 05/19/23